We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$4.46B
AUM Growth
+$668M
Cap. Flow
+$960M
Cap. Flow %
21.54%
Top 10 Hldgs %
62.58%
Holding
61
New
4
Increased
2
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
COUR icon
Coursera
COUR
+$952M
2
MILE
Metromile, Inc. Common Stock
MILE
+$143M
3
SVRA icon
Savara
SVRA
+$41.3M
4
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$18.2M
5
VTGN icon
VistaGen Therapeutics
VTGN
+$15.4M

Top Sells

Rank Stock Value
1
SPT icon
Sprout Social
SPT
+$96.8M
2
PANW icon
Palo Alto Networks
PANW
+$95.5M
3
DZSI
DZS Inc. Common Stock
DZSI
+$15.3M
4
SENS icon
Senseonics Holdings Inc
SENS
+$9.97M
5
AFMD
Affimed
AFMD
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 52.55%
2 Consumer Staples 21.37%
3 Industrials 10.31%
4 Technology 6.37%
5 Financials 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
26
DELISTED
Verona Pharma
VRNA
$42.7M 0.96%
5,108,563
– –
GRTX
27
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$38.5M 0.86%
4,362,986
– –
BE icon
28
Bloom Energy
BE
$65B
$36.1M 0.81%
1,333,333
– –
VTGN icon
29
VistaGen Therapeutics
VTGN
$13.5M
$34.7M 0.78%
543,420
+231,420
+74% +$15.4M
ELVN icon
30
Enliven Therapeutics
ELVN
$4.41B
$33.9M 0.76%
1,004,293
– –
LITS
31
Lite Strategy Inc
LITS
$32.3M
$29.3M 0.66%
426,654
– –
AVEO
32
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$28.9M 0.65%
3,952,958
– –
TCON
33
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$28.5M 0.64%
17,336
– –
GNCA
34
DELISTED
Genocea Biosciences, Inc.
GNCA
$28.1M 0.63%
10,376,936
– –
CBIO
35
Crescent Biopharma
CBIO
$618M
$27.4M 0.61%
90,890
– –
MRKR icon
36
Marker Therapeutics
MRKR
$18.5M
$24M 0.54%
1,071,429
+571,429
+114% +$13.1M
PHAS
37
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$23M 0.52%
6,643,704
– –
GERN icon
38
Geron
GERN
$969M
$21.3M 0.48%
13,461,538
– –
CTIC
39
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$20.8M 0.47%
7,140,450
– –
CSBR icon
40
Champions Oncology
CSBR
$72.7M
$19.4M 0.43%
1,713,720
– –
MTCR
41
DELISTED
Metacrine, Inc. Common Stock
MTCR
$19M 0.43%
3,062,977
– –
XENE icon
42
Xenon Pharmaceuticals
XENE
$6.09B
$17.8M 0.4%
992,107
– –
STSA
43
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$17.7M 0.4%
+2,997,682
New +$18.2M
TRVI icon
44
Trevi Therapeutics
TRVI
$2.59B
$16.1M 0.36%
5,940,796
– –
IVA
45
Inventiva
IVA
$1.16B
$15.3M 0.34%
1,041,666
– –
SYBX
46
DELISTED
Synlogic
SYBX
$15.1M 0.34%
281,961
– –
OBSV
47
DELISTED
ObsEva SA Ordinary Shares
OBSV
$14.9M 0.33%
4,586,563
– –
LXRX icon
48
Lexicon Pharmaceuticals
LXRX
$1.03B
$14M 0.31%
2,382,286
– –
SBBP
49
DELISTED
Strongbridge Biopharma plc.
SBBP
$11.4M 0.26%
4,141,308
– –
RGLS
50
DELISTED
Regulus Therapeutics
RGLS
$10.1M 0.23%
645,106
– –
1
2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

NEA Management Company's Q1 2021 Portfolio in Review

As of Q1 2021, NEA Management Company held 61 positions worth $4.46B, up 18% from $3.79B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

NEA Management Company deployed $960M of net new capital in Q1 2021, opening 4 new positions and adding to 2 existing holdings. Its largest new stake was Coursera: 21,156,891 shares worth $952M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 66% a quarter earlier, followed by Consumer Staples and Industrials.

On the sell side, the largest reduction was Sprout Social, an estimated $96.8M trimmed.

  • NEA Management Company's largest Q1 2021 buy was Coursera: 21,156,891 shares worth $952M.
  • NEA Management Company added most to VistaGen Therapeutics in Q1 2021, an estimated $15.4M increase.
  • NEA Management Company's biggest Q1 2021 reduction was Sprout Social, cutting an estimated $96.8M.
  • NEA Management Company fully exited Palo Alto Networks in Q1 2021, selling an estimated $95.5M.
  • NEA Management Company's ten largest holdings make up 63% of its $4.46B portfolio in Q1 2021.
  • NEA Management Company opened 4 new positions and closed 3 in Q1 2021.
  • NEA Management Company's portfolio value rose 18% quarter-over-quarter to $4.46B.

Based on NEA Management Company's 13F filing for Q1 2021, filed 14 May 2021.